Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-03

FDA Approved: FYREMADEL — Supplemental Application (Ferring Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for FYREMADEL (ganirelix acetate) submitted by Ferring Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FYREMADEL (GANIRELIX ACETATE)

Snippet

SUPPL AP for FYREMADEL (GANIRELIX ACETATE)